Cite
A Prospective Cohort Study of Metformin as an Adjuvant Therapy for Infertile Women With Endometrial Complex Hyperplasia/Complex Atypical Hyperplasia and Their Subsequent Assisted Reproductive Technology Outcomes
MLA
Wei-ya Kong, et al. “A Prospective Cohort Study of Metformin as an Adjuvant Therapy for Infertile Women With Endometrial Complex Hyperplasia/Complex Atypical Hyperplasia and Their Subsequent Assisted Reproductive Technology Outcomes.” Frontiers in Endocrinology, vol. 13, June 2022. EBSCOhost, https://doi.org/10.3389/fendo.2022.849794.
APA
Wei-ya Kong, Zheng-ai Liu, Na Zhang, Xue Wu, Xing-bo Zhao, & Lei Yan. (2022). A Prospective Cohort Study of Metformin as an Adjuvant Therapy for Infertile Women With Endometrial Complex Hyperplasia/Complex Atypical Hyperplasia and Their Subsequent Assisted Reproductive Technology Outcomes. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.849794
Chicago
Wei-ya Kong, Zheng-ai Liu, Na Zhang, Xue Wu, Xing-bo Zhao, and Lei Yan. 2022. “A Prospective Cohort Study of Metformin as an Adjuvant Therapy for Infertile Women With Endometrial Complex Hyperplasia/Complex Atypical Hyperplasia and Their Subsequent Assisted Reproductive Technology Outcomes.” Frontiers in Endocrinology 13 (June). doi:10.3389/fendo.2022.849794.